Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients

/PRNewswire/ -- Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now...

Related Keywords

Combivent Respimat ,Michele Baer ,Jean Michel Boers ,Boehringer Ingelheim United States Corporation ,Human Pharma Communications ,Boehringer Ingelheim ,Boehringer Cares Foundation ,Boehringer Ingelheim United States ,Boehringer Cares ,Inhalation Aerosol ,Prescribing Information ,Patient Instructions ,Inhalation Spray ,Safety Information ,Patient Information ,